BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9801713)

  • 1. Severe mental illness and addictions: assessment considerations.
    Carey KB; Correia CJ
    Addict Behav; 1998; 23(6):735-48. PubMed ID: 9801713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A scale for assessing the stage of substance abuse treatment in persons with severe mental illness.
    McHugo GJ; Drake RE; Burton HL; Ackerson TH
    J Nerv Ment Dis; 1995 Dec; 183(12):762-7. PubMed ID: 8522938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral interventions for dual-diagnosis patients.
    Goldsmith RJ; Garlapati V
    Psychiatr Clin North Am; 2004 Dec; 27(4):709-25. PubMed ID: 15550289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and consequences of the dual diagnosis of substance abuse and severe mental illness.
    Buckley PF
    J Clin Psychiatry; 2006; 67 Suppl 7():5-9. PubMed ID: 16961418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mental illness and substance misuse: a nursing challenge.
    Jackson-Koku G
    Br J Nurs; 2001 Feb 22-Mar 7; 10(4):242-6. PubMed ID: 12170649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clients with substance abuse and mental health concerns: a guide for conducting intake interviews.
    Brems C; Johnson ME; Namyniuk LL
    J Behav Health Serv Res; 2002 Aug; 29(3):327-34. PubMed ID: 12216376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.
    Bellack AS; Bennett ME; Gearon JS; Brown CH; Yang Y
    Arch Gen Psychiatry; 2006 Apr; 63(4):426-32. PubMed ID: 16585472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global Appraisal of Individual Needs Short Screener (GSS): psychometric properties and performance as a screening measure in adolescents.
    McDonell MG; Comtois KA; Voss WD; Morgan AH; Ries RK
    Am J Drug Alcohol Abuse; 2009; 35(3):157-60. PubMed ID: 19462299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV.
    Hasin D; Samet S; Nunes E; Meydan J; Matseoane K; Waxman R
    Am J Psychiatry; 2006 Apr; 163(4):689-96. PubMed ID: 16585445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dartmouth Assessment of Lifestyle Instrument (DALI): a substance use disorder screen for people with severe mental illness.
    Rosenberg SD; Drake RE; Wolford GL; Mueser KT; Oxman TE; Vidaver RM; Carrieri KL; Luckoor R
    Am J Psychiatry; 1998 Feb; 155(2):232-8. PubMed ID: 9464203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dual diagnosis typology to improve diagnosis and treatment of dual disorder patients.
    Zimberg S
    J Psychoactive Drugs; 1999; 31(1):47-51. PubMed ID: 10332638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Planning Treatment and Assessing Recovery in Participants With Dual Diagnosis: Preliminary Evaluation of a New Clinical Tool.
    Noel V; Woods M; Routhier J; Drake R
    J Dual Diagn; 2016; 12(1):55-62. PubMed ID: 26828850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An agency-generated outcome measure.
    Blakely TJ; Dziadosz GM
    Care Manag J; 2007; 8(3):113-9. PubMed ID: 17937209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing substance use disorder in persons with severe mental illness.
    Drake RE; Rosenberg SD; Mueser KT
    New Dir Ment Health Serv; 1996; (70):3-17. PubMed ID: 8754227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dually diagnosed patient with psychotic symptoms.
    Ries RK
    J Addict Dis; 1993; 12(3):103-22. PubMed ID: 8251538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers.
    Hasin DS; Trautman KD; Miele GM; Samet S; Smith M; Endicott J
    Am J Psychiatry; 1996 Sep; 153(9):1195-201. PubMed ID: 8780425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinically useful assessments: substance use and comorbid psychiatric disorders.
    Carey KB
    Behav Res Ther; 2002 Nov; 40(11):1345-61. PubMed ID: 12384329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mental illness and substance use: an Australian perspective.
    Munro I; Edward KL
    Int J Ment Health Nurs; 2008 Aug; 17(4):255-60. PubMed ID: 18666908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of comorbidity: major mental illness and problematic substance use.
    Siegfried N
    Aust N Z J Psychiatry; 1998 Oct; 32(5):707-17. PubMed ID: 9805595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing clinical outcomes: the community functioning of persons with serious mental illness.
    Dickerson FB
    Psychiatr Serv; 1997 Jul; 48(7):897-902. PubMed ID: 9219297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.